Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn

JAMA Netw Open. 2021 Sep 1;4(9):e2127454. doi: 10.1001/jamanetworkopen.2021.27454.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunity, Humoral
  • RNA, Messenger
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • RNA, Messenger